SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

細胞アッセイの技術と世界市場

Cell-Based Assays: Technologies and Global Markets

細胞アッセイの技術と世界市場

商品番号 : SMB-74172

出版社BCC Research
出版年月2025年2月
ページ数139
価格タイプシングルユーザライセンス
価格USD 4,650
種別英文調査報告書

細胞アッセイの世界市場は、2024年から2029年にかけて年平均成長率（CAGR）9.8%で拡大し、2024年の353億ドルから2029年には563億ドルに達するとBCC Researchでは予測しています。

「細胞アッセイの技術と世界市場 – Cell-Based Assays: Technologies and Global Markets」は世界の細胞エッセイ（セルベースエッセイ）を主要セグメント別に分析・予測したBCC Researchの市場調査レポートです。

主な掲載内容

  • エグゼクティブサマリー
  • 市場概観
    • 創薬
    • 細胞アッセイの重要性
    • 細胞アッセイの種類
    • 細胞アッセイの用途
  • 市場力学
    • 市場成長促進要因
    • 市場成長阻害要因
    • 市場機会
  • エマージングテクノロジーと開発
    • エマージングテクノロジー
    • 特許分析
  • セグメント別市場分析
    • 細胞アッセイ市場分析：製品タイプ
    • 細胞アッセイ市場分析：用途
    • 細胞アッセイ市場分析：エンドユーザ
    • 細胞アッセイ市場分析：地域
  • 競合情報
    • 競合勢力図
    • 細胞アッセイ市場における企業ランキング
  • 細胞アッセイアイジョウにおける持続可能性：ESGパースペクティブ
  • 付録

Report Highlights

The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Summary:

The global cell-based assay market was $32.4 billion in 2023 and is expected to grow at a CAGR of 9.8% to reach $56.3 billion by the end of 2029. The market’s growth is propelled by multiple factors that contribute to its expansion across many sectors, particularly in drug discovery, toxicity testing, and basic research. Cell-based assays, which utilize live cells to evaluate biological activity, are revolutionizing the life sciences industry by offering more accurate and physiologically relevant models compared to traditional methods such as animal testing. As these assays continue to evolve, they are helping to accelerate drug development processes, improving the efficacy and safety profiles of therapeutic candidates while also reducing animal testing and increasing cost efficiency.

世界の細胞ベースアッセイ市場は2023年に324億ドルで、2029年末までに9.8%のCAGRで成長し、563億ドルに達すると予想されています。市場の成長は、特に創薬、毒性試験、基礎研究など、多くの分野での拡大に寄与する複数の要因によって推進されています。生きた細胞を使用して生物学的活性を評価する細胞ベースアッセイは、動物実験などの従来の方法と比較して、より正確で生理学的に関連のあるモデルを提供することで、ライフサイエンス業界に革命をもたらしています。これらのアッセイは進化し続けており、医薬品開発プロセスの加速、治療候補の有効性と安全性プロファイルの改善に役立ち、動物実験の削減とコスト効率の向上にもつながります。

A driver of the cell-based assay market is the increasing demand for novel drug discovery techniques. Pharmaceutical and biotech companies are investing in cell-based assays for high-throughput screening (HTS) to identify potential drug candidates, to evaluate drug efficacy, and to assess compound toxicity early in the drug development process. Compared to traditional biochemical assays, cell-based assays provide more predictive, human-relevant data, which is fundamental for the successful development of new therapeutics. As the pharmaceutical industry seeks to reduce the cost and time of bringing drugs to market, cell-based assays are being adopted as a more efficient alternative.

Additionally, the rise in chronic diseases such as cancer, cardiovascular disease (CVD), diabetes, and neurological disorders is driving the need for more effective and targeted therapies. As these diseases continue to affect a large portion of the global population, the demand for cell-based assays in both basic and clinical research has grown. Researchers are using these assays to better understand disease mechanisms at the cellular level, to identify potential biomarkers, and to evaluate drug responses more accurately. This has led to a surge in R&D investment to advance new cell-based assay technologies.。

Report Scope

The scope of this report on the global market for cell-based assay technologies encompasses an analysis of the current landscape, including market size, growth trends and segmentation by product type, application and end user. The report breaks down the cell-based assay market into four product categories: instruments, consumables, services, and software. It also segments the market by application, such as drug discovery; absorption, distribution, metabolism, and excretion (ADME)/toxicity testing; and basic research. The end users considered in the report include academic and research institutions, pharmaceutical and biotech companies, and clinical research organizations.

細胞ベースのアッセイ技術の世界市場に関するこのレポートの範囲には、市場規模、成長傾向、製品タイプ、用途、エンドユーザーによるセグメント化など、現在の状況の分析が含まれます。レポートでは、細胞ベースのアッセイ市場を機器、消耗品、サービス、ソフトウェアの 4 つの製品カテゴリに分類しています。また、医薬品の発見、吸収、分布、代謝、排泄 (ADME)/毒性試験、基礎研究などのアプリケーション別に市場をセグメント化しています。レポートで検討されているエンドユーザーには、学術機関、研究機関、製薬会社、バイオテクノロジー会社、臨床研究組織が含まれます。

Geographically, the analysis covers North America, Europe, Asia-Pacific, and Rest of the World (RoW). The report also provides profiles of key market players and highlights industry trends, major products, mergers and acquisitions, and other partnerships expected to influence the future of the industry.

地理的には、分析は北米、ヨーロッパ、アジア太平洋、その他の地域 (RoW) をカバーしています。レポートでは、主要な市場プレーヤーのプロファイルも提供し、業界の動向、主要製品、合併と買収、および業界の将来に影響を与えると予想されるその他のパートナーシップを強調しています。

Report Synopsis

Report MetricsDetails
Base year considered2023
Forecast period considered2024-2029
Base year market size$32.4 billion
Market size forecast$56.3 billion
Growth rateCAGR of 9.8% for the forecast period of 2024-2029
Units considered$ Millions
Segments coveredProduct Type, Application, End-User, Region
Regions coveredNorth America, Europe, Asia-Pacific, Rest of the World
Countries coveredU.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Austria, Sweden, Switzerland, Denmark, China, India, Japan, South Korea, Australia, Singapore, Thailand, Vietnam, Indonesia, Latin America, Middle East Africa
Key Market Drivers
  • Rising Incidence of Chronic Diseases
  • Rising Demand for Drug Discovery and Development
  • High Demand for Personalized Medicine
  • Increasing Investment in Drug R&D
Companies studied
AGILENT TECHNOLOGIES INC.BD
BIOIVTBIO-RAD LABORATORIES INC.
CELL BIOLABS INC.CELL BIOLOGICS INC.
CHARLES RIVER LABORATORIESDANAHER CORP.
FUJIFILM HOLDINGS CORP.GE HEALTHCARE
LONZAMERCK KGAA
PROMEGA CORP.REVVITY
THERMO FISHER SCIENTIFIC INC.

Report Includes

– 23 data tables and 48 additional tables

– Analyses of the trends in the global market for cell-based assays, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029

– Evaluation of the market’s current and future potential

– Estimates of the market for cell-based assays, revenue forecasts, and corresponding market share analysis by product, type/application, end user and geographic region

– Assessment of the current market, new developments, spending trends, and revenue prospects for cell-based assays in the pharmaceutical industry

– Coverage of major issues involved in the R&D of more effective cell-based approaches for drug discovery

– Information on increasing investments in R&D activities, key technology issues, industry-specific challenges, major types of end users, and COVID-19 implications

– Discussion of ESG challenges and practices of the industry

– Assessment of the competitive landscape, including the market shares of leading companies, their product portfolios and financial overviews

– Information on recent mergers and acquisitions, expansions, collaborations, investments, divestments and product launches

– Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Merck KGaA., Danaher Corp., Bio-Rad Laboratories Inc., and Charles River Laboratories.

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Summary

Chapter 2 Market Overview

Overview

Drug Discovery

Importance of Cell-based Assays

Cell Signaling Pathways

Mechanisms of Drug Action

Gene Expression Regulation

Cytotoxicity and Viability

Disease Modeling

Types of Cell-based Assays

Cell Viability Assays

Cell Proliferation Assays

Cytotoxicity Assays

Application of Cell-based Assays

Drug Discovery and Development

Toxicology Studies

Cancer Research

Infectious Disease Research

Immunology and Inflammation

Molecular Pathway Analysis

Regenerative Medicine and Tissue Engineering

Biomarker Discovery and Validation

Precision and Personalized Medicine

Chapter 3 Market Dynamics

Overview

Market Drivers

Rising Incidence of Chronic Diseases

Rising Demand for Drug Discovery and Development

High Demand for Personalized Medicine

Increasing Investment in Drug R&D

Market Restraints

High Cost of Assay Development and Maintenance

Technical Challenges and Complexity

Short Shelf-life of Reagents and Consumables

Market Opportunities

Expanding Applications in Drug Discovery

Expansion in Diagnostics and Biomarker Discovery

Chapter 4 Emerging Technologies and Developments

Overview

Emerging Technologies

CRISPR/Cas9 Technology

High-content Screening (HCS) and Imaging

AI and Machine Learning (ML) in Data Analysis

Patent Analysis

Patent Review, by Leading Jurisdiction

Chapter 5 Market Segmentation Analysis

Overview

Segmentation Breakdown

Cell-based Assays: Global Markets

Market Analysis by Product Type

Consumables

Instruments

Software

Services

Market Analysis by Application

Drug Discovery

Absorption, Distribution, Metabolism, and Excretion (ADME)/Toxicity

Basic Research

Market Analysis by End User

Biotechnology and Pharmaceutical Companies

Academic and Research Institutes

Contract Research Organizations

Geographic Breakdown

Market Analysis by Region

North America

Europe

Asia-Pacific

Rest of the World

Chapter 6 Competitive Intelligence

Competitive Landscape

Ranking of Companies in the Cell-based Assay Market

Chapter 7 Sustainability in Cell-based Assay Market: An ESG Perspective

Sustainability in the Cell-based Assay Market

Animal Testing

Miniaturization and Automation

Green Chemistry and Eco-friendly Materials

3D Cell Cultures and Tissue Models

Waste Reduction and Optimization of Resources

Improving Drug Discovery Efficiency

ESG Risks and Ratings: Understanding the Data

BCC Research Viewpoint

Chapter 8 Appendix

Methodology

Sources

Abbreviations

Company Profiles

AGILENT TECHNOLOGIES INC.

BD

BIOIVT

BIO-RAD LABORATORIES INC.

CELL BIOLABS INC.

CELL BIOLOGICS INC.

CHARLES RIVER LABORATORIES

DANAHER CORP.

FUJIFILM HOLDINGS CORP.

GE HEALTHCARE

LONZA

MERCK KGAA

PROMEGA CORP.

REVVITY

THERMO FISHER SCIENTIFIC INC.

List of Tables

Summary Table A : Global Market for Cell-based Assays, by Product Type, Through 2029

Summary Table B : Global Market for Cell-based Assays, by Region, Through 2029

Table 1 : Factors in Cell-based Assay Development

Table 2 : Types of Cellular Assays

Table 3 : New Cases and Deaths Due to Selected Cancers Globally, 2022

Table 4 : U.S. NIH Funding for Selected Diseases, 2019–2023

Table 5 : Existing Cell-based Assay Technologies

Table 6 : Patents Issued for Cell-based Assays, by Jurisdiction, 2022-2024

Table 7 : Global Market for Cell-based Assays, Through 2029

Table 8 : Global Market for Cell-based Assays, by Product Type, Through 2029

Table 9 : Global Market for Cell-based Assays, by Application, Through 2029

Table 10 : Global Market for Cell-based Assays, by End User, Through 2029

Table 11 : Global Market for Cell-based Assays, by Region, Through 2029

Table 12 : North American Market for Cell-based Assays, by Country, Through 2029

Table 13 : European Market for Cell-based Assays, by Country, Through 2029

Table 14 : Asia-Pacific Market for Cell-based Assays, by Country, Through 2029

Table 15 : RoW Market for Cell-based Assays, by Subregion, Through 2029

Table 16 : Ranking of Companies in Cell-based Assay Market, 2023

Table 17 : ESG Rankings for Major Cell-based Assay Companies, 2024*

Table 18 : Information Sources in This Report

Table 19 : Abbreviations Used in this Report

Table 20 : Agilent Technologies Inc.: Company Snapshot

Table 21 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023

Table 22 : Agilent Technologies Inc.: Product Portfolio

Table 23 : Agilent Technologies Inc.: News/Key Developments, 2024

Table 24 : BD: Company Snapshot

Table 25 : BD: Financial Performance, FY 2023 and 2024

Table 26 : BD: Product Portfolio

Table 27 : BD: News/Key Developments, 2024

Table 28 : BioIVT: Company Snapshot

Table 29 : BioIVT: Product Portfolio

Table 30 : BioIVT: News/Key Developments, 2023 and 2024

Table 31 : Bio-Rad Laboratories Inc.: Company Snapshot

Table 32 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023

Table 33 : Bio-Rad Laboratories Inc.: Product Portfolio

Table 34 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024

Table 35 : Cell Biolabs Inc.: Company Snapshot

Table 36 : Cell Biolabs Inc.: Product Portfolio

Table 37 : Cell Biologics Inc.: Company Snapshot

Table 38 : Cell Biologics Inc.: Product Portfolio

Table 39 : Charles River Laboratories: Company Snapshot

Table 40 : Charles River Laboratories: Financial Performance, FY 2022 and 2023

Table 41 : Charles River Laboratories: Product Portfolio

Table 42 : Charles River Laboratories: News/Key Developments, 2023 and 2024

Table 43 : Danaher Corp.: Company Snapshot

Table 44 : Danaher Corp.: Financial Performance, FY 2022 and 2023

Table 45 : Danaher Corp.: Product Portfolio

Table 46 : Fujifilm Holdings Corp.: Company Snapshot

Table 47 : Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023

Table 48 : Fujifilm Holdings Corp.: Product Portfolio

Table 49 : GE Healthcare: Company Snapshot

Table 50 : GE Healthcare: Financial Performance, FY 2022 and 2023

Table 51 : GE Healthcare: Product Portfolio

Table 52 : Lonza: Company Snapshot

Table 53 : Lonza: Financial Performance, FY 2022 and 2023

Table 54 : Lonza: Product Portfolio

Table 55 : Lonza: News/Key Developments, 2021

Table 56 : Merck KGaA: Company Snapshot

Table 57 : Merck KGaA: Financial Performance, FY 2022 and 2023

Table 58 : Merck KGaA: Product Portfolio

Table 59 : Promega Corp.: Company Snapshot

Table 60 : Promega Corp.: Product Portfolio

Table 61 : Promega Corp.: News/Key Developments, 2023

Table 62 : Revvity: Company Snapshot

Table 63 : Revvity: Financial Performance, FY 2022 and 2023

Table 64 : Revvity: Product Portfolio

Table 65 : Revvity: News/Key Developments, 2023 and 2024

Table 66 : Thermo Fisher Scientific Inc.: Company Snapshot

Table 67 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023

Table 68 : Thermo Fisher Scientific Inc.: Product Portfolio

Table 69 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024

List of Figures

Summary Figure A : Global Market for Cell-based Assays, by Product Type, 2021-2029

Summary Figure B : Global Market for Cell-based Assays, by Region, 2021-2029

Figure 1 : Projected Global Aging Population (65 Years and Above), 1990-2050

Figure 2 : Drug Discovery Process Steps

Figure 3 : Market Dynamics of Cell-based Assays

Figure 4 : FDA Approval of Personalized Medicines, 2015-2022

Figure 5 : Pharmaceutical R&D Spending, by Country/Region, 2010-2022

Figure 6 : Shares of Global Market for Cell-based Assays, by Product Type, 2023

Figure 7 : Shares of Global Market for Cell-based Assays, by Application, 2023

Figure 8 : Shares of Global Market for Cell-based Assays, by End User, 2023

Figure 9 : R&D Spending of Biopharmaceutical Companies, 2010-2024

Figure 10 : Shares of Global Market for Cell-based Assays, by Region, 2023

Figure 11 : Shares of North American Market for Cell-based Assays, by Country, 2023

Figure 12 : Shares of European Market for Cell-based Assays, by Country, 2023

Figure 13 : Shares of Asia-Pacific Market for Cell-based Assays, by Country, 2023

Figure 14 : Shares of RoW Market for Cell-based Assays, by Subregion, 2023

Figure 15 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023

Figure 16 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023

Figure 17 : BD: Revenue Share, by Business Unit, FY 2024

Figure 18 : BD: Revenue Share, by Country/Region, FY 2024

Figure 19 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023

Figure 20 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023

Figure 21 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023

Figure 22 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023

Figure 23 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023

Figure 24 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023

Figure 25 : Fujifilm Holdings Corp.: Revenue Share, by Business Unit, FY 2023

Figure 26 : Fujifilm Holdings Corp.: Revenue Share, by Country/Region, FY 2023

Figure 27 : GE Healthcare: Revenue Share, by Business Unit, FY 2023

Figure 28 : GE Healthcare: Revenue Share, by Country/Region, FY 2023

Figure 29 : Lonza: Revenue Share, by Business Unit, FY 2023

Figure 30 : Merck KGaA: Revenue Share, by Business Unit, FY 2023

Figure 31 : Merck KGaA: Revenue Share, by Country/Region, FY 2023

Figure 32 : Revvity: Revenue Share, by Business Unit, FY 2023

Figure 33 : Revvity: Revenue Share, by Country/Region, FY 2023

Figure 34 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023

Figure 35 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023

バイオ技術の最新記事8件